Pabal, Injektionslösung

7680580790015 CH-58079 Injektionslösung
Pabal, Injektionslösung
Pabal, Injektionslösung
Pabal, Injektionslösung
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
27/02/2024
Summary of Product Characteristics
Français
27/02/2024
Summary of Product Characteristics
Italien
27/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.386 MG Substance HBESI

Authorization holder

Ferring AG

6340 Baar

Authorization information

Swissmedic authorization number
58079
Drug name
Pabal, Injektionslösung
Galenic form
LSINJ
ATC Code
H01BB03
Authorization status
Z
Dispensing category
A
First authorization
21/10/2008
Authorization expiration date
31/12/9999
IT Number
07.03.2.
Domain
Human medicine
Field of application
Prävention uteriner Blutungen aufgrund einer postpartalen Uterusatonie

Package details

Description (FR)
PABAL sol inj 100 mcg/ml 5 flac 1 ml
Description (DE)
PABAL Inj Lös 100 mcg/ml 5 Durchstf 1 ml
Market launch
21/10/2008
Narcotic (BTM)
No